Construction of an HCC recurrence model basedon the investigation of immune-relatedlncRNAs and related mechanisms

Bibliographic Details
Title: Construction of an HCC recurrence model basedon the investigation of immune-relatedlncRNAs and related mechanisms
Authors: Xiang-Xu Wang, Li-Hong Wu, Liping Ai, Wei Pan, Jing-Yi Ren, Qiong Zhang, Hong-Mei Zhang
Source: Molecular Therapy: Nucleic Acids, Vol 26, Iss , Pp 1387-1400 (2021)
Publisher Information: Elsevier, 2021.
Publication Year: 2021
Collection: LCC:Therapeutics. Pharmacology
Subject Terms: hepatocellular carcinoma, recurrence, lncRNA, immune microenvironment, ceRNA, Therapeutics. Pharmacology, RM1-950
More Details: Long noncoding RNAs (lncRNAs) are emerging as critical regulators of gene expression and play fundamental roles in immune regulation. Growing evidence suggests that immune-related genes and lncRNAs can serve as markers to predict the prognosis of patients with cancers, including hepatocellular carcinoma (HCC). This study aimed to contract an immune-related lncRNA (IR-lncRNA) signature for prospective assessment to predict early recurrence of HCC. A total of 319 HCC samples under radical resection were randomly divided into a training cohort (161 samples) and a testing cohort (158 samples). In the training dataset, univariate, lasso, and multivariate Cox regression analyses identified a 9-IR-lncRNA signature closely related to disease-free survival. Kaplan-Meier analysis, principal component analysis, gene set enrichment analysis, and nomogram were used to evaluate the risk model. The results were further confirmed in the testing cohort. Furthermore, we constructed a competitive endogenous RNA regulatory network. The results of the present study indicated that this 9-IR-lncRNA signature has important clinical implications for improving predictive outcomes and guiding individualized treatment in HCC patients. These IR-lncRNAs and regulated genes may be potential biomarkers associated with the prognosis of HCC.
Document Type: article
File Description: electronic resource
Language: English
ISSN: 2162-2531
Relation: http://www.sciencedirect.com/science/article/pii/S216225312100281X; https://doaj.org/toc/2162-2531
DOI: 10.1016/j.omtn.2021.11.006
Access URL: https://doaj.org/article/33d778e44f4c4536b45e072f06514a99
Accession Number: edsdoj.33d778e44f4c4536b45e072f06514a99
Database: Directory of Open Access Journals
More Details
ISSN:21622531
DOI:10.1016/j.omtn.2021.11.006
Published in:Molecular Therapy: Nucleic Acids
Language:English